Clinical Trial Update: The Study of IBI310 in Combination With IBI308 Compared to High-Dose Interferon In Patients With Acral Melanoma That Has Been Removed by Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating IBI310 in combination with IBI308 versus high-dose interferon in acral melanoma that has been removed by surgery; study status terminat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acral Melanoma

Drugs mentioned

• IBI308 (IBI308)
• IBI310 (IBI310)
• Interferon (interferon)

Snippet

Sponsor: Innovent Biologics (Suzhou) Co. Ltd. | Conditions: Acral Melanoma That Has Been Removed by Surgery | Phase 3 | Status: TERMINATED